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Abstract
Background: The identification of protein domains plays an important role in protein structure
comparison. Domain query size and composition are critical to structure similarity search
algorithms such as the Vector Alignment Search Tool (VAST), the method employed for computing
related protein structures in NCBI Entrez system. Currently, domains identified on the basis of
structural compactness are used for VAST computations. In this study, we have investigated how
alternative definitions of domains derived from conserved sequence alignments in the Conserved
Domain Database (CDD) would affect the domain comparisons and structure similarity search
performance of VAST.
Results: Alternative domains, which have significantly different secondary structure composition
from those based on structurally compact units, were identified based on the alignment footprints
of curated protein sequence domain families. Our analysis indicates that domain boundaries
disagree on roughly 8% of protein chains in the medium redundancy subset of the Molecular
Modeling Database (MMDB). These conflicting sequence based domain boundaries perform slightly
better than structure domains in structure similarity searches, and there are interesting cases when
structure similarity search performance is markedly improved.
Conclusion: Structure similarity searches using domain boundaries based on conserved sequence
information can provide an additional method for investigators to identify interesting similarities
between proteins with known structures. Because of the improvement in performance of structure
similarity searches using sequence domain boundaries, we are in the process of implementing their
inclusion into the VAST search and MMDB resources in the NCBI Entrez system.
Background
As the amount of diverse biological data continues to
grow, it is important for new methods of analysis to be
devised and current methods to be improved. The ability
to detect that two proteins have diverged from a common
ancestor allows one to infer functional similarity between
the two. A common method for identifying similarity
between proteins is the use of sequence alignment tools
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such as FASTA [1] and BLAST [2], which provide an align-
ment of two sequences and a score indicating whether the
alignment is significant or could be attributed to chance.
The comparison of protein structures allows one to peer
back farther into evolutionary time, based on the concept
that a form or structure remains similar long after
sequence similarity has become undetectable [3-6]. There
are many methods [7-15] and databases [16-19] currently
available for protein structure comparisons. While the
performance of the methods and databases available are
for the most part satisfactory, it is not unusual for such
methods to miss certain biologically related protein struc-
tures that may be identified by human inspection. One
may consider two directions when attempting to improve
the ability to detect structural similarity. The first is to
improve the similarity search method itself, either by
using a novel approach for constructing an alignment or
by optimizing an existing method. The second approach
is to improve the definition of the objects to be compared
by the methods. Although initial reflection on the two
possibilities may indicate the first may be most fruitful,
there is indeed a great deal that may be done with the data
itself.
It has long been understood that there is an intermediate
organization in proteins, typically called a domain, that is
greater than secondary structure and less than the full-
length chain of amino acids [20-22]. This fact considera-
bly complicates the problems of sequence and structural
alignment, because it is possible that two long proteins
may contain a similar common domain, which is much
smaller than either of the entire proteins. Ideally we want
to recognize this situation, but it is difficult to detect true
similarity of small subregions while at the same time
excluding the small similarities that may occur due to
chance. One part of the solution lies in testing for statisti-
cal significance of alignment scores or various similarity
measures; but even so, it is possible for small but impor-
tant similarities to be missed. Another part of the solu-
tion, which is possible in the case of structure comparison,
is to identify the smaller subregions of potential similarity
(the domains) and to directly compare them.
Thus, it becomes critical to identify the domains appropri-
ately before performing structure similarity searches.
Structurally compact domains are currently being used for
computing related structures in MMDB. Recent studies
investigating the performance of several structurally based
domain parsers in comparison to expert curated structure
domain boundaries have indicated the limitations of dif-
ferent methods and potential improvements [23,24].
Here we ask the questions, "How often do structurally
identified domain boundaries disagree with those deter-
mined by sequence conservation" and "Does either
domain type perform better in structure similarity
searches when disagreement occurs?"
In this study, taking advantage of the availability of large
collections of manually curated domains based on conser-
vation among sequences across a protein family, we inves-
tigated how the structure search performance of VAST
would be affected when using sequence-based and struc-
ture-based protein domains. A sequence-based domain
can generally be defined as an evolutionarily conserved
region of a protein. Domains of this type are identified as
similar blocks of residues occurring in several proteins.
Currently there are many databases of these domains such
as Pfam[25], SMART[26,27], and the Conserved Domain
Database (CDD) [28,29], generally built up from multi-
ple sequence alignments and hidden Markov model
methods. A structure-based domain can be defined as a
three dimensionally isolated region, and is considered by
some to correspond to a compact folding unit. Structure-
based domains are generally identified by manual inspec-
tion of a protein structure, as is the case with the Structural
Classification of Proteins (SCOP) database[17], or by
computationally delineating compact substructures as is
done in the MMDB. Although in most cases the domains
that are derived from sequence and structural ideas are
consistent, there are times when the boundaries do not
agree. An example of a common domain boundary disa-
greement can be seen in human ABL1 tyrosine kinase
(PDB id: 2FO0, chain: A) (Figure 1) and is observed in
many kinases. In this instance, the MMDB structure
domain parser has divided the chain into four domains,
as there are four geometrically distinct regions. However,
two of the structure domains occur together with similar
residue content across a diverse range of species in suffi-
cient instances to be identified as a single domain, the
tyrosine kinase catalytic domain (CDD id: cd00192),
based on sequence analysis. In this case, we would want
to investigate if combining both structure-based domains
into a single domain would allow for detection of similar-
ity to other kinases while avoiding detection of similarity
to unrelated structures where smaller regions share a com-
mon arrangement of helices and strands.
In this work, we first systematically compared the domain
boundaries of the sequence-based domains in the Con-
served Domain Database to the structure-based domains
in the medium redundancy subset of MMDB. We have
identified a noticeable fraction of sequence based
domains that differ significantly from those derived based
on structural compactness. The new domains were then
used as queries in identifying related structures using
VAST and changes in structure similarity search results
were analyzed. Using SCOP as a standard of truth, inter-
esting cases were observed where the new domain bound-
aries perform better than the original domains in terms ofBMC Structural Biology 2009, 9:33 http://www.biomedcentral.com/1472-6807/9/33
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Example of sequence/structure domain disagreement due to difference in concept Figure 1
Example of sequence/structure domain disagreement due to difference in concept. The structure of ABL1 tyrosine 
kinase (PDB id: 2FO0, chain A) and the sequence domains SH3, SH2, and tyrosine kinase C-terminal region (CDD ids: 
cd00174, cd00173, cd00192). Structure based domains shown as cartoons in purple, blue, brown and light green. Sequence 
based C-terminal tyrosine kinase domain shown in red, SH3 shown in dark green, SH2 shown in yellow represented as thick 
backbone trace. The schematic of domain arrangement shows full protein chain, structure domains 1 through 4, and the three 
sequence domains.BMC Structural Biology 2009, 9:33 http://www.biomedcentral.com/1472-6807/9/33
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homologous structure recognition. We have also found
that the overall performance of sequence domains is com-
parable to that of whole chain and structure domain
based queries.
Results and Discussion
Comparison of structure similarity search results
Having tested a series of thresholds for identification of
differences between sequence and structure-based
domains as described in the methods section, we focused
on the structure similarity search results using sequence
based domains for which at least 90% of the domain con-
sensus sequence was aligned to a structure. A sequence
based domain was determined to be different from exist-
ing structure based domains when its secondary structure
composition was at least four secondary structure ele-
ments (SSEs) different from both the most similar struc-
ture domain and the entire protein chain. These results are
derived from applying the methods to the medium redun-
dancy subset of MMDB, in which the structure database is
reduced by clustering similar structures based on
sequence similarity and then selecting a single representa-
tive from each cluster based on structure quality [30]. We
report our analysis results based on the non-redundant
data set, though application of the methods and analysis
to the larger non-identical subset of MMDB yielded simi-
lar performance of structure similarity searches. In addi-
tion, although we present the full analysis on older
versions of the databases, recalculations using more recent
version of the databases revealed similar ratios of domain
differences found. The search for domain differences on
the 6231 chains in the medium redundancy set identified
635 sequence domains on 495 protein chains. Of the dif-
ferences found, one-third of the sequence domains fall
within single structure based domain, whereas the
remainder join regions of multiple structure domains.
Since this study is looking at the performance of different
queries using the same search method and database,
search performance can be assessed simply by comparing
the ratio of homologs identified to all similarities identi-
fied for the two query sets, the original structure based
domains and chains and the new sequence derived
domains. The sequence-based domains do perform
slightly better as queries than the original domains, hav-
ing a search result set consisting of 21% homologous
structures as opposed to 15% for the original domains
(Table 1). Since one of the benefits of structure similarity
searches is the ability to detect similarity at larger evolu-
tionary distances and lower sequence similarity, we also
used the same ratio method to assess performance with
regards to the results falling in different sequence similar-
ity groups. The result sets for each query type were divided
into two bins, search hits with percent sequence identity
greater than 20% against the query domain sequence and
those with less than 20%. Again, sequence domains are
performing slightly better based on the homolog ratios,
with the hits having greater than 20% sequence identity
consisting of 75% homologs for the sequence based
domains as compared to 65% for the structure domains,
and hits with sequence identity falling below the "twilight
zone" of 20% consisting of 16% homologs as compared
to 11% (Table 1). This second set of ratios shows that the
sequence domain queries are not simply identifying a
greater ratio of homologous sequence similar hits, but are
indeed allowing the detection of distant homologs with
minimal sequence similarity to the queries. Inspection of
the raw numbers as opposed to the ratios shows that the
sequence domain queries have a result set less than half
the size of the result set for the structure domains. It is
expected that the primary cause of this reduction is the
nature of the method used. In order to verify that the
sequence domain were identifying new hits previously
being missed, we tested the performance of structure
searches using both the original structure domains that
were overlapped by the sequence domain, as well as using
the entire chain as a query for searches, as all of these have
structure search results provided in MMDB. This results in
a minimum of two comparable original structure queries
for each new sequence domain tested, and should account
for the raw increase in total number of structure search
hits. Nevertheless, the sequence based domains detect
roughly 10% more unique structure neighbors when con-
sidered as an additional domain resource. ROC curves
(data not shown) based on the percent identity between
the queries and results revealed very similar performance
of the structure and sequence based domains. The com-
parison of ROC curves based on percent identity for the
structure domain based results and the additional hits
found by sequence domain similarity shows a slight
increase in performance. This indicates that the addition
of sequence domains to the MMDB/VAST service would
not degrade the overall performance of the system, while
detecting additional homologs.
Table 1: VAST Search results for domains with boundary conflict from the medium redundancy subset of MMDB.
Structure Domains 
Total
Sequence Domains 
Total
Structure Domains 
(> = 20% Id)
Sequence Domains 
(> = 20% Id)
Structure Domains 
(<20% Id)
Sequence Domains 
(<20% Id)
Homologs Found 9790 (15%) 5476 (21%) 2592 (65%) 1814 (75%) 7198 (11%) 3662 (16%)
Total Hits 65150 25560 3994 2416 61156 23144BMC Structural Biology 2009, 9:33 http://www.biomedcentral.com/1472-6807/9/33
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A primary goal of this study was to determine if providing
an additional automated resource to investigators allow-
ing structure searches using alternate domain boundaries
when endpoint conflict occurs could be beneficial. Our
interest is not to seek domain definition replacement, but
rather to see whether additional biologically relevant
insight can be gained by using additional automatically
generated domain sets. The analyses do reveal interesting
new similarities that justify the inclusion of the sequence
domain search results as an additional domain resource
within MMDB. In the following two examples, we explore
the scenarios of how structure domain and sequence
domain can differ and the effects of the new boundaries
on structure similarity search results.
DNA topoisomerase I
The sequence based eukaryotic DNA topoisomerase-I cat-
alytic core domain (CDD id: pfam01028) covers residues
231 to 466 which stretches across structure domains 2, 3,
and 4 of human DNA topoisomerase-I (PDB id: 1RRJ,
chain A) (Figure 2). The sequence domain consists of 8
helices and 5 strands, which includes all SSEs of the orig-
inal structure domains 2 and 3, and a single helix of struc-
ture domain 4. This appears to be a case where the
Domain boundaries in human DNA topoisomerase I Figure 2
Domain boundaries in human DNA topoisomerase I. DNA topoisomerase from human (PDB id: 1RRJ, CDD id: 
pfam01028). Structure domains 1, 2, 3, and 4 are shown in magenta, blue, brown, and green in the structure and domain 
arrangement schematic, the DNA topoisomerase catalytic sequence based domain is shown in yellow.BMC Structural Biology 2009, 9:33 http://www.biomedcentral.com/1472-6807/9/33
Page 6 of 10
(page number not for citation purposes)
structure domain parser is excessively splitting the protein
chain, and based on conserved sequence information,
regions of several structure domains generally occur
together. Inspection of other human topoisomerase-I
structures reveals all have been structurally parsed with
similar domain arrangements where the sequence conser-
vation of the catalytic core domain covers a discontinuous
structure domain and a small sequentially internal
domain. By using the sequence domain boundaries, the
only homolog detected by the original domains is found
as well as two additional remote homologs (Table 2). We
anticipate the same effect would be observed for other
DNA topisomerase-Is which have similarly parsed struc-
ture domains. This example shows that the altered SSE
composition associated with the sequence based domain
allows for new 'hits' to be identified in the first VAST step
of SSE vector alignment, thus helping to improve sensitiv-
ity in homolog recognition. In this example, not only
does the sequence domain allow for the identification of
new homologous structures, it also has the specificity ben-
efit of eliminating the detection of similarity to all non-
homologous structures previously found. The drastic
increase in specificity led us to validate this performance
gain by broadening our definition of homologous struc-
tures. We reanalyzed the search results of the structure
domains using the SCOP fold group as our potential
homolog set (Table 2). This verification did not result in
the reclassification of any non-homologous similarities,
confirming that in this case the alternative domain allows
for the detection of additional homologous structures
while eliminating detection of structures that do not share
a common ancestor with the query.
Fibronectin
The sequence based Fibronectin type-II domain (CDD id:
cd00062) eliminates the entire N-terminal region and
reduces the C-terminal region of the discontinuous struc-
ture domain 1 of the gelatin binding region of human
Fibronectin (PDB id: 1E88, chain A). This region covers
residues 110 to 158 and consists of all but one of the 7 C-
terminal strands (Figure 3). In this instance, it is easy to
visualize how the parser judged the N- and C-terminal
regions as packed together and distinct from structure
domain two, although there is a visual distinction
between the two discontinuous regions of domain 1.
Inspection of the structure similarity search results shows
searching with the individual fibronectin domain identi-
fied by sequence allows the identification of twice as
many homologs at the cost of a single non-homolog
based on SCOP superfamily and fold group classification,
with some variability in the number of residues and SSEs
aligned of common hits (Table 3). This increase in per-
formance may be attributed to the fact that although in
many cases individual fibronectin domains occur
together, the way they pack together biologically or crys-
tallographically may not be the same; thus searches with
the individual regions are more advantageous in detecting
similar domains in a variety of arrangements and confor-
mations.
Table 2: VAST Search results for Topoisomerase-I from human.
PDB Id and Chain Structure Domain 
Hit
Sequence Domain 
Hit
Superfamily 
Member
Fold Group 
Member
SSEs Aligned Residues Aligned % Identity
1F34 B+ 4 3 2 1 3 %
1HUM A+ 4 2 5 8 %
1MGS A+ 4 2 4 1 3 %
1ASS _+ 5 3 1 3 %
2EOT _+ 4 2 2 0 %
1EIG A+ 4 2 6 0 %
1HFG A+ 4 2 3 2 2 %
1AIH A + + + + 5 (9) 72 (126) 25% (9%)
1A41 _ + + + (7) (103) (23%)
4CRX A + + + (9) (139) (12%)
Scores for sequence based domains shown in parentheses.BMC Structural Biology 2009, 9:33 http://www.biomedcentral.com/1472-6807/9/33
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Conclusion
Our investigation shows that although conflicting
domain boundaries occur relatively infrequently, when
disagreement occurs there is a slight gain in performance
in the overall structure similarity search results by using
sequence-based domain boundaries. While the improve-
ment in performance is not consistently better for all dif-
ferences identified, more structure neighbors are
identified in general, and there are noticeable instances
where there is a marked increase in the ability to distin-
guish homologs from non-homlogs in search results. As
the number and quality of curated sequence conservation
based protein domain families improves over time, the
impact of sequence based domains on biologically related
structure recognition could become more significant and
it is clearly beneficial to add sequence based domains in
automatic fashion when computing related structures in
MMDB. We are in the process of implementing the inclu-
sion of sequence domains into the protein structure
resources in the Entrez system at NCBI. MMDB protein
structure pages will soon allow for inspection of similar
structures detected using sequence domains and the VAST
search service will allow such sequence based domains to
be identified automatically in user submitted structures,
Domain boundaries in human fibronectin Figure 3
Domain boundaries in human fibronectin. Gelatin binding region from human fibronectin (PDB id: 1E88, chain A, CDD 
id: cd00062) Structure domains 1 and 2 are shown in magenta and blue in the structure and domain arrangement schematic, 
the fibronectin type-II sequence based domain is shown in yellow.BMC Structural Biology 2009, 9:33 http://www.biomedcentral.com/1472-6807/9/33
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permitting these subregions to be used as queries for struc-
ture similarity searches. The addition of sequence domain
boundaries to these services will allow investigators to
potentially identify interesting new relationships between
protein structures that were previously undetected, and
similar screening methods could easily be applied to other
search systems.
Methods
Identifying sequence domains disagreeing with structure 
domains
The April 2005 Conserved Domain Database (CDD) and
medium redundancy Molecular Modeling Database
(MMDB) were used for the sequence to structure domain
comparisons, the current versions of which are available
at http://www.ncbi.nlm.nih.gov/Structure/cdd/cdd.shtml
and http://www.ncbi.nlm.nih.gov/Structure/MMDB/
mmdb.shtml. Of the Conserved Domain Database,
entries derived from the Clusters of Orthologous
Groups[31,32] database were excluded, as they tend to be
full gene products containing multiple sequence and
structure domains. Each domain profile from the CDD
was compared to the sequence of protein structures in our
subset of MMDB. These comparisons involved using the
sequence of MMDB entries as queries in RPS-BLAST
against our subset of the CDD, using a 'hit' expectation
value threshold of 0.01 and a requirement that at least
90% of a Conserved Domain (CD) sequence be aligned to
a query to be considered for comparison. We also tested
the effect of reducing the percentage of CD sequence
alignment required for boundary difference comparisons.
Since these tests resulted in few additional domain identi-
fications at the cost of reduced sequence alignment
length, we focused on our most stringent 90% alignment
coverage requirement. Because the CDD is collected from
several database sources, some domains in the database
are very similar, thus sequence domains are curated into
domain families. When collecting the set of sequence
domains, if multiple sequence domains from the same
family aligned to a protein structure, a family representa-
tive was chosen based on the following criteria: 1) The
domain family member with the greatest percentage
alignment was chosen, and 2) if more than one domain
family member had the same percentage alignment, the
member with shorter overall length was chosen.
The SSE compositions of the sequence domains were then
compared to the composition of the entire chain on
which the sequence domain was identified, as well as the
domains of the chain identified based on compactness. A
SSE composition metric was used, rather than an amino
acid sequence difference requirement, because the VAST
algorithm applied later in the study uses SSE alignment to
detect protein similarity. By requiring different SSE com-
position, we avoided the potential identification of
domain differences resulting from the inclusion or
removal of unstructured protein regions which would
have no effect on structural similarity searches employed
later in the study. The footprint of a sequence domain was
considered different from the structure domains based on
the following criteria: 1) The sequence domain must con-
tain at least 4 secondary structure elements (SSEs), 2) the
sequence domain must be at least 4 SSEs shorter than the
whole chain, and 3) the sequence domain must be at least
4 SSEs different from the closest structure based domain.
SSEs and structure domains for a given structure were
those identified by the MMDB structure domain parser.
Item 1) simply means that we are not considering very
small domains with 3 or fewer SSEs, which corresponds
fairly well to having 50 or fewer residues. Items 2) and 3)
define when we consider a sequence domain to be "differ-
ent" from a structure-based domain. Additional SSE dif-
ference requirements were tested, and as expected,
reducing the number of SSEs required resulted in many
domain differences identified, while more SSEs required
for being classified as different quickly reduced the
number of differences found. This testing led us to select
the 4 SSE difference requirement as a "middle ground",
allowing us to identify a large number of domain differ-
ences without selecting all sequence based domains in the
Table 3: VAST Search results for gelatin binding region of human fibronectin.
PDB Id and 
Chain
Structure 
Domain Hit
Sequence 
Domain Hit
Superfamily 
Member
Fold Group 
Member
SSEs Aligned Residues Aligned % Identity
2FN2 _ + + + + 7 (5) 49 (39) 100% (100%)
1H8P A + + + + 5 (5) 34 (35) 41% (43%)
1PDC _ +++ ( 5 ) ( 2 7 ) ( 4 8 % )
1J7M A +++ ( 5 ) ( 4 7 ) ( 5 5 % )
1MJD A + (4) (17) (12%)
Scores for sequence based domains shown in parentheses.BMC Structural Biology 2009, 9:33 http://www.biomedcentral.com/1472-6807/9/33
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structure database. The choice of 4 SSEs is natural, because
this is about the size of a small domain, and it should
allow us to clearly see the effect of using different domain
boundaries in the structure similarity searches. The closest
structure domain to a sequence domains was determined
as follows: a) the structure domain completely covered by
the sequence domain, b) the longest structure domain
completely covered by the sequence domain, or c) the
structure domain with the longest length covered by the
sequence domain. To test the possibility that domain dif-
ferences were due to unaligned ends of the sequence
domains not being included in the regions to be used as
queries, we repeated the method using the July 2005 data-
bases in which the sequence domain boundaries were
extended to the ends of the complete sequence domains
and tested using the same SSE difference requirements
described above. Differences in the size and composition
of the footprint and extended footprint sets were then
compared, revealing minimal differences in the domains
identified as different. A flowchart of the order of opera-
tions can be seen in Figure 4.
Structure similarity search assessment
The domain entries from MMDB and sequence domains
identified as different were used as queries for structure
similarity searches against the medium redundancy set of
MMDB using Vector Alignment Search Tool (VAST), avail-
able on the web at http://www.ncbi.nlm.nih.gov/Struc
ture/VAST/vast.shtml. VAST is essentially a two-phase
process, the first being the alignment of vectors of second-
ary structure and preliminary scoring. Those initial align-
ments whose scores exceed an empirically derived
threshold are then refined in the second phase of struc-
tural alignment using the Ca coordinates. Only those
refined alignments with a statistical significance of P < 10-
5 are reported as structurally similar. Although available to
the public on the web, our study used an in-house version
of the VAST executable to allow the submission of multi-
ple queries and more efficient use of computational
resources. To evaluate the change in structure similarity
search results when using the new domains based on
sequence, we considered structurally similar domains
classified within the same superfamily division as the
query domain of SCOP 1.69, available at http://scop.mrc-
lmb.cam.ac.uk/scop/, to be homologs. Since the study
explicitly looked for differences in domain boundaries, it
was not possible to directly map both structure and
sequence domains to corresponding entries in the SCOP
database. For example, if a structure domain from MMDB
has very similar domain boundaries as a SCOP domain,
then a sequence domain found to be different from the
MMDB domain would also be different from a SCOP
domain definition. Thus, in order to measure the ability
to identify similar domains, a homolog set for a query
domain was identified as the SCOP superfamily members
for all SCOP domains identified on the query chain.
Although this 'collapsing' of superfamilies on a chain
could introduce the possibility of some false homolog
mapping or unrealistically large homolog sets, it allowed
for sensitivity and specificity analysis of individual
domains in the test set as well as overall assessment of the
domain based structure similarity search result sets. In
addition, to avoid missing data issues due to the smaller
Order of operations for identifying domain differences Figure 4
Order of operations for identifying domain differ-
ences. Databases are shown as squashed rectangles, results 
as rectangles, operations as diamonds, and endpoint as a 
rounded rectangle.BMC Structural Biology 2009, 9:33 http://www.biomedcentral.com/1472-6807/9/33
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size of the SCOP database, all domains used as VAST que-
ries and resulting similar structures were reduced to only
those structures included in the 1.69 release of SCOP.
Individual search results were also evaluated using SCOP
fold classification members to test the possibly that previ-
ously identified non-homologs were potentially distant
homologous structures that were not included in the
superfamily classification. The structure similarity search
results for each domain query and domain type sets were
then compared based on the homologous and non-
homologous structures found, as well as search result
overlap, e.g. hits common to both sequence and structure
domain similarity search results, regardless of the signifi-
cance scores of the alignment other than the statistical sig-
nificance of P < 10-5 required for being reported as similar
by the VAST algorithm. Individual search results of the
new domains were then compared to results of the origi-
nal structure domains and visualized using PyMOL [33]
and Cn3D [34].
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